Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer

Masahiro Sakaguchi, Arvind Virmani, Marla W. Dudak, George N. Peters, A. Marilyn Leitch, Hossein Saboorian, Adi F. Gazdar, David M. Euhus

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background: The mammary sentinel lymph node procedure can increase the detection of axillary metastases by 45% compared with standard axillary dissection. Some investigators have reported that reverse transcriptase- polymerase chain reaction (RT-PCR) increases metastasis detection even more, but it is uncertain whether a positive RT-PCR test in the face of a negative histological evaluation is clinically meaningful. Methods: RT-PCR for epithelial glycoprotein 2 and cytokeratin 19 was performed on sentinel and pooled nonsentinel axillary lymph nodes from 108 women with clinical stage I or II breast cancer who were followed up for a median of 40 months. Results: Axillary metastases were detected on standard tissue sections in 26% and by RT-PCR in 30%. Results for the two tests were concordant for 80% of the cases. RT-PCR upstaged 16%. Tumors from women whose lymph nodes were positive only by RT-PCR were phenotypically similar to those from women with no metastases detected by any method. Moreover, 4-year actuarial distant disease-free survival was 100% for women with metastases detected by RT-PCR only, as compared with 74% for those with metastases detected by routine histology (P = .03) and 93% for those with no metastases detected by either method (P = .04). Conclusions: Analysis of sentinel lymph nodes by RT-PCR for epithelial glycoprotein 2 and cytokeratin 19 is unlikely to provide clinically useful information.

Original languageEnglish (US)
Pages (from-to)117-125
Number of pages9
JournalAnnals of Surgical Oncology
Volume10
Issue number2
DOIs
StatePublished - 2003

Fingerprint

Reverse Transcriptase Polymerase Chain Reaction
Lymph Nodes
Breast Neoplasms
Neoplasm Metastasis
Keratin-19
Glycoproteins
Disease-Free Survival
Dissection
Histology
Breast
Research Personnel
Neoplasms

Keywords

  • Breast cancer
  • Cytokeratin-19
  • EGP-2
  • RT-PCR
  • Sentinel nodes
  • Survival

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer. / Sakaguchi, Masahiro; Virmani, Arvind; Dudak, Marla W.; Peters, George N.; Leitch, A. Marilyn; Saboorian, Hossein; Gazdar, Adi F.; Euhus, David M.

In: Annals of Surgical Oncology, Vol. 10, No. 2, 2003, p. 117-125.

Research output: Contribution to journalArticle

Sakaguchi, Masahiro ; Virmani, Arvind ; Dudak, Marla W. ; Peters, George N. ; Leitch, A. Marilyn ; Saboorian, Hossein ; Gazdar, Adi F. ; Euhus, David M. / Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer. In: Annals of Surgical Oncology. 2003 ; Vol. 10, No. 2. pp. 117-125.
@article{f1e88c5a918d42f0b6cc6f0099fa3326,
title = "Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer",
abstract = "Background: The mammary sentinel lymph node procedure can increase the detection of axillary metastases by 45{\%} compared with standard axillary dissection. Some investigators have reported that reverse transcriptase- polymerase chain reaction (RT-PCR) increases metastasis detection even more, but it is uncertain whether a positive RT-PCR test in the face of a negative histological evaluation is clinically meaningful. Methods: RT-PCR for epithelial glycoprotein 2 and cytokeratin 19 was performed on sentinel and pooled nonsentinel axillary lymph nodes from 108 women with clinical stage I or II breast cancer who were followed up for a median of 40 months. Results: Axillary metastases were detected on standard tissue sections in 26{\%} and by RT-PCR in 30{\%}. Results for the two tests were concordant for 80{\%} of the cases. RT-PCR upstaged 16{\%}. Tumors from women whose lymph nodes were positive only by RT-PCR were phenotypically similar to those from women with no metastases detected by any method. Moreover, 4-year actuarial distant disease-free survival was 100{\%} for women with metastases detected by RT-PCR only, as compared with 74{\%} for those with metastases detected by routine histology (P = .03) and 93{\%} for those with no metastases detected by either method (P = .04). Conclusions: Analysis of sentinel lymph nodes by RT-PCR for epithelial glycoprotein 2 and cytokeratin 19 is unlikely to provide clinically useful information.",
keywords = "Breast cancer, Cytokeratin-19, EGP-2, RT-PCR, Sentinel nodes, Survival",
author = "Masahiro Sakaguchi and Arvind Virmani and Dudak, {Marla W.} and Peters, {George N.} and Leitch, {A. Marilyn} and Hossein Saboorian and Gazdar, {Adi F.} and Euhus, {David M.}",
year = "2003",
doi = "10.1245/ASO.2003.01.010",
language = "English (US)",
volume = "10",
pages = "117--125",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer

AU - Sakaguchi, Masahiro

AU - Virmani, Arvind

AU - Dudak, Marla W.

AU - Peters, George N.

AU - Leitch, A. Marilyn

AU - Saboorian, Hossein

AU - Gazdar, Adi F.

AU - Euhus, David M.

PY - 2003

Y1 - 2003

N2 - Background: The mammary sentinel lymph node procedure can increase the detection of axillary metastases by 45% compared with standard axillary dissection. Some investigators have reported that reverse transcriptase- polymerase chain reaction (RT-PCR) increases metastasis detection even more, but it is uncertain whether a positive RT-PCR test in the face of a negative histological evaluation is clinically meaningful. Methods: RT-PCR for epithelial glycoprotein 2 and cytokeratin 19 was performed on sentinel and pooled nonsentinel axillary lymph nodes from 108 women with clinical stage I or II breast cancer who were followed up for a median of 40 months. Results: Axillary metastases were detected on standard tissue sections in 26% and by RT-PCR in 30%. Results for the two tests were concordant for 80% of the cases. RT-PCR upstaged 16%. Tumors from women whose lymph nodes were positive only by RT-PCR were phenotypically similar to those from women with no metastases detected by any method. Moreover, 4-year actuarial distant disease-free survival was 100% for women with metastases detected by RT-PCR only, as compared with 74% for those with metastases detected by routine histology (P = .03) and 93% for those with no metastases detected by either method (P = .04). Conclusions: Analysis of sentinel lymph nodes by RT-PCR for epithelial glycoprotein 2 and cytokeratin 19 is unlikely to provide clinically useful information.

AB - Background: The mammary sentinel lymph node procedure can increase the detection of axillary metastases by 45% compared with standard axillary dissection. Some investigators have reported that reverse transcriptase- polymerase chain reaction (RT-PCR) increases metastasis detection even more, but it is uncertain whether a positive RT-PCR test in the face of a negative histological evaluation is clinically meaningful. Methods: RT-PCR for epithelial glycoprotein 2 and cytokeratin 19 was performed on sentinel and pooled nonsentinel axillary lymph nodes from 108 women with clinical stage I or II breast cancer who were followed up for a median of 40 months. Results: Axillary metastases were detected on standard tissue sections in 26% and by RT-PCR in 30%. Results for the two tests were concordant for 80% of the cases. RT-PCR upstaged 16%. Tumors from women whose lymph nodes were positive only by RT-PCR were phenotypically similar to those from women with no metastases detected by any method. Moreover, 4-year actuarial distant disease-free survival was 100% for women with metastases detected by RT-PCR only, as compared with 74% for those with metastases detected by routine histology (P = .03) and 93% for those with no metastases detected by either method (P = .04). Conclusions: Analysis of sentinel lymph nodes by RT-PCR for epithelial glycoprotein 2 and cytokeratin 19 is unlikely to provide clinically useful information.

KW - Breast cancer

KW - Cytokeratin-19

KW - EGP-2

KW - RT-PCR

KW - Sentinel nodes

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0038460325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038460325&partnerID=8YFLogxK

U2 - 10.1245/ASO.2003.01.010

DO - 10.1245/ASO.2003.01.010

M3 - Article

C2 - 12620905

AN - SCOPUS:0038460325

VL - 10

SP - 117

EP - 125

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 2

ER -